SCHEMBL5309381

SCHEMBL5309381

O=C(O)C(c1ccccc1C(F)(F)F)C1CCCNC1

nearest known ligand 0.46

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 12/20 0.46
SLC6A4 P31645 12/20 0.46
SLC6A3 Q01959 4/20 0.43
CPN1 P15169 1/20 0.41
CPB2 Q96IY4 1/20 0.41
CHRM4 P08173 1/20 0.40
CYP3A4 P08684 1/20 0.40
CHRM5 P08912 1/20 0.40
CYP2D6 P10635 1/20 0.40
MEN1 O00255 1/20 0.38
CYP1A2 P05177 1/20 0.38
KMT2A Q03164 1/20 0.38
CNR1 P21554 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5332290 0.92 SLC6A2 (0.48) SLC6A2SLC6A4SLC6A3CHRM4CYP3A4
SCHEMBL4720830 0.84 HTR2C (0.47) SLC6A2SLC6A4SLC6A3
SCHEMBL27124181 0.81 CPN1 (0.43) SLC6A2SLC6A4SLC6A3CPN1CPB2
SCHEMBL27132169 0.80 CPN1 (0.41) SLC6A2SLC6A4SLC6A3CPN1CPB2
SCHEMBL27410776 0.78 CPN1 (0.49) SLC6A2SLC6A4SLC6A3CPN1CPB2
SCHEMBL27123836 0.75 CPN1 (0.39) SLC6A2SLC6A4SLC6A3CPN1CPB2
SCHEMBL16475935 0.70 CPN1 (0.47) SLC6A2SLC6A4SLC6A3CPN1CPB2
SCHEMBL5789580 0.70 PTPN1 (0.41) CNR1
SCHEMBL18547184 0.69 SLC6A2 (0.47) SLC6A2SLC6A4SLC6A3CYP2D6
SCHEMBL31066542 0.69 SLC6A2 (0.47) SLC6A2SLC6A4SLC6A3CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1805141-A1 PIPERIDINES AND RELATED COMPOUNDS FOR TREATMENT OF ALZHEIMER'S DISEASE MERCK SHARP & DOHME LTD. (GB) 2007-07-11 EP disclosed
WO-2006043064-A1 PIPERIDINES AND RELATED COMPOUNDS FOR TREATMENT OF ALZHEIMER'S DISEASE MERCK SHARP & DOHME LIMITED (GB) 2006-04-27 WO disclosed